Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare Therapeutics's platform combines CRISPR‐enabled gene-editing target discovery technology with high‐resolution protein crystallography, computational biology, medicinal chemistry, and clinical informatics.